Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1550
+0.0150 (10.71%)
Aug 10, 2026, 3:47 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 15.29 million as of August 10, 2026. Its market cap has decreased by -7.45% in one year.
Market Cap
15.29M
Enterprise Value
15.04M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 15.29M, an increase of 130.32%. That is a compound annual growth rate of 20.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 15.29M | 27.68% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 28.51M |
| Sharp Therapeutics | 27.37M |
| Lobe Sciences | 24.65M |
| Alzai Health | 22.77M |
| Devonian Health Group | 21.55M |
| Hemostemix | 13.85M |
| Rapid Dose Therapeutics | 12.28M |
| PreveCeutical Medical | 12.24M |